The protective effects of irisin against blood–brain barrier (BBB) dysfunction following focal cerebral ischemia/reperfusion in rats are accompanied by decreases in the expression and activity of matrix metalloproteinase-9 (MMP-9) in the cortex [86]. This evidence concerns the gene MMP9 and Cerebral ischemia.